The effect of mycophenolate mofetil on patients with active non-renal SLE [3]

Clinical and Experimental Rheumatology

Volumn 25, Issue 6, 2007, Pages 932-

  Moder, Kevin G ^a   Amin, S ^a   Mazlumzadeh, M ^a   Crowson, C ^a   Ytterberg, S ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DOUBLE STRANDED DNA; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STUDENT T TEST; SUBARACHNOID HEMORRHAGE; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 38649111382     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. MODER KG: Mycophenolate mofetil: New applications for this immunosuppressant. Ann Allergy Asthma Immunol 2003; 90:15-19; quiz 20.
2. CHAN TM, LI FK, TANG CSO et al.: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. New Engl J Med 2000; 343: 1156-62.
3. CHAN TM, TSE KC, TANG CSO, MOK MY, LI FK: Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 2005; 16: 1076-84.
4. ONG LM, HOOI LS, LIM TO et al.: Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology 2005; 10: 504-10.
5. GINZLER EM, DOOLEY MA, ARANOW C et al.: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. New Engl J Med 2005; 353: 2219-28.
6. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
7. LIANG MH, SOCHER SA, LARSON MG, SCHUR PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18.